Check out what we’ve been up to and where can we connect!
Results of the Adaptive COVID-19 Treatment Trial (ACTT)-2 investigating combination treatment with baricitinib, a Janus kinase inhibitor, and remdesivir for the treatment of COVID-19 in hospitalized adults were published in the New England Journal of Medicine (NEJM) on March 4, 2021, showing that the combination treatment was superior to remdesivir alone.
March 29, 2021
Phase I/II studies to evaluate human placental hematopoietic stem cell–derived natural killer (NK) cell therapy to treat COVID-19 in hospitalized adults are currently ongoing as part of our partnership with the Infectious Disease Research Institute (IDRI).
February 8, 2021
In a recent podcast discussion with TrialSite News, Claudia Christian, Senior Vice President, Clinical Operations at FHI Clinical, shares how the company’s experience in complex clinical research in resource-limited settings helps to ensure health equity and get life-saving vaccines to those who need them most.
November 20, 2020
The U.S. FDA granted emergency use authorization (EUA) for the use of baricitinib in combination with remdesivir to treat COVID-19 in hospitalized adults and children at least two years of age requiring supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.
FHI Clinical is proud to support Making it Plain: the Colors of COVID Barbershop and Salon Talk including our Scientific Advisory Expert, Dr. Stephen Thomas, PhD.
April 29, 2021
Biomedical researchers, clinical research organizations, people infected and impacted by the pandemic, along with Black barbers and stylists, will come together in a virtual event April 29 at 6 p.m. to provide straight talk about fears, trust issues, and why we need our Black and Brown community to be part of COVID-19 vaccine research.
April 20-22, 2021
Attending the Global Forum on TB Vaccines? Visit our booth to learn more about our services or schedule a meeting with our team.
April 21, 2021
Join us for this panel discussion in which experts in infectious diseases will discuss the effect of WHO recommendations around TPT for individuals at high risk of TB infection and increased TPT use on TB vaccine development.
March 26, 2021
Bring all your questions about things like vaccine hesitancy, equitable vaccine distribution and other issues facing the black community to “Colors of COVID-19 Barber Shop and Salon Talk.”
November 15-19, 2020
Attending the ASTMH 2020 Annual Meeting? Schedule a meeting with an FHI Clinical team member who will be in attendance at the event or stop by our booth
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA